Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
Background & Aims Patients with inflammatory bowel diseases (IBDs) (Crohn’s disease, ulcerative colitis) are at increased risk of colorectal cancer (CRC). Persistent inflammation is hypothesized to increase risk of CRC in patients with IBD; however, the few studies in this area have been restri...
Main Authors: | Ananthakrishnan, Ashwin N., Cheng, Su–Chun, Cai, Tianxi, Cagan, Andrew, Gainer, Vivian S., Szolovits, Peter, Shaw, Stanley Y., Churchill, Susanne, Karlson, Elizabeth W., Murphy, Shawn N., Kohane, Isaac, Liao, Katherine P. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/101061 https://orcid.org/0000-0001-8411-6403 |
Similar Items
-
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016) -
Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016) -
Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016) -
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases
by: Ananthakrishnan, A. N., et al.
Published: (2016) -
Improving the power of genetic association tests with imperfect phenotype derived from electronic medical records
by: Sinnott, Jennifer A., et al.
Published: (2016)